Meril Life Sciences Pvt Ltd (Meril), a subsidiary of Bilakhia Holdings Pvt Ltd, is a medical device company that designs, develops and manufactures medical devices. The company offers various products which include vascular intervention medical devices, diagnostic equipment and instruments, orthopedic implants, ENT medical devices, endo-surgery products and cardiac surgery products. It sells its products under the brand names BioMime, Mesire, MIRUS, Quantilyte, AutoQuant 400i, CliniQuant, FREEDOM, Haiku, Obtura, NAUTICA, MyVal, MERICRON XL, BioMime Lineage, BioMime Morph, BioMime Branch, Metafor, Proficient, NexGen and MOZEC, among others. The company operates in the US, South Africa, India, Bangladesh, Brazil, Germany, Belgium and Turkey. Meril is headquartered in Vapi, Gujarat, India.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Meril Life Sciences Pvt Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Meril Life Sciences Pvt Ltd Company Overview
- Meril Life Sciences Pvt Ltd Company Snapshot
- Meril Life Sciences Pvt Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Meril Life Sciences Pvt Ltd - Pipeline Analysis Overview
- Meril Life Sciences Pvt Ltd - Key Facts
- Meril Life Sciences Pvt Ltd - Major Products and Services
- Meril Life Sciences Pvt Ltd Pipeline Products by Development Stage
- Meril Life Sciences Pvt Ltd Ongoing Clinical Trials by Trial Status
- Meril Life Sciences Pvt Ltd Pipeline Products Overview
- Bulls-Eye
- Bulls-Eye Product Overview
- CALIX-R
- CALIX-R Product Overview
- CommFort
- CommFort Product Overview
- COVIFIND Rapid Antigen Self-Test
- COVIFIND Rapid Antigen Self-Test Product Overview
- CrocoDial Compass
- CrocoDial Compass Product Overview
- Daffodil AV
- Daffodil AV Product Overview
- Daffodil MV
- Daffodil MV Product Overview
- Dafodil DRI
- Dafodil DRI Product Overview
- EmboNest
- EmboNest Product Overview
- Embox
- Embox Product Overview
- Interlace BRS
- Interlace BRS Product Overview
- Mammoth NEO
- Mammoth NEO Product Overview
- Melange BRS
- Melange BRS Product Overview
- Melange BRS Clinical Trial
- MeRes100
- MeRes100 Product Overview
- MeRes100 Clinical Trial
- Miltonia-UNO
- Miltonia-UNO Product Overview
- Mitva
- Mitva Product Overview
- MyVal 2
- MyVal 2 Product Overview
- MyVal Genesis
- MyVal Genesis Product Overview
- MyVal Hexa
- MyVal Hexa Product Overview
- Myval Rondevu
- Myval Rondevu Product Overview
- MyVal S/Ex
- MyVal S/Ex Product Overview
- Navigator 2
- Navigator 2 Product Overview
- Navigator Neo
- Navigator Neo Product Overview
- Navigator Rondevu
- Navigator Rondevu Product Overview
- OctAlign
- OctAlign Product Overview
- PeriTi
- PeriTi Product Overview
- Plugit
- Plugit Product Overview
- Python Novela
- Python Novela Product Overview
- Senarius
- Senarius Product Overview
- Zotomime
- Zotomime Product Overview
- Meril Life Sciences Pvt Ltd - Key Competitors
- Meril Life Sciences Pvt Ltd - Key Employees
- Meril Life Sciences Pvt Ltd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Meril Life Sciences Pvt Ltd, Recent Developments
- Mar 07, 2023: Maxx Orthopedics announces Farzin Khaghani as Chief Commercial Officer
- Nov 18, 2019: MyVal transcatheter heart valve reports positive trial results
- Jul 11, 2019: MeRes100 BRS - the world's first thin strut sirolimus-eluting bioresorbable vascular scaffold - shows consistent long-term positive safety with consistent low mace rates and zero scaffold stent thrombosis for patients with coronary artery disease
- Apr 29, 2019: First successful hip replacement surgery completed with Libertas Hip System
- Mar 10, 2014: Freedom Knee Revision Knee System Receives US FDA 510(k) Clearance Ahead of American Academy of Orthopaedic Surgeons Meeting
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Meril Life Sciences Pvt Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Meril Life Sciences Pvt Ltd Pipeline Products by Equipment Type
- Meril Life Sciences Pvt Ltd Pipeline Products by Indication
- Meril Life Sciences Pvt Ltd Ongoing Clinical Trials by Trial Status
- Meril Life Sciences Pvt Ltd, Key Facts
- Meril Life Sciences Pvt Ltd, Major Products and Services
- Meril Life Sciences Pvt Ltd Number of Pipeline Products by Development Stage
- Meril Life Sciences Pvt Ltd Pipeline Products Summary by Development Stage
- Meril Life Sciences Pvt Ltd Ongoing Clinical Trials by Trial Status
- Meril Life Sciences Pvt Ltd Ongoing Clinical Trials Summary
- Bulls-Eye - Product Status
- Bulls-Eye - Product Description
- CALIX-R - Product Status
- CALIX-R - Product Description
- CommFort - Product Status
- CommFort - Product Description
- COVIFIND Rapid Antigen Self-Test - Product Status
- COVIFIND Rapid Antigen Self-Test - Product Description
- CrocoDial Compass - Product Status
- CrocoDial Compass - Product Description
- Daffodil AV - Product Status
- Daffodil AV - Product Description
- Daffodil MV - Product Status
- Daffodil MV - Product Description
- Dafodil DRI - Product Status
- Dafodil DRI - Product Description
- EmboNest - Product Status
- EmboNest - Product Description
- Embox - Product Status
- Embox - Product Description
- Interlace BRS - Product Status
- Interlace BRS - Product Description
- Mammoth NEO - Product Status
- Mammoth NEO - Product Description
- Melange BRS - Product Status
- Melange BRS - Product Description
- Melange BRS - A Prospective, Multicentre, Open Label Clinical Study to Evaluate Safety and Performance of Melange BRS Sirolimus Eluting Bioresorbable Peripheral Scaffold System for Use as an Adjunct to Percutaneous Transluminal Renal Angioplasty of Atherosclerotic De Novo or Restenotic Lesion of the Renal Artery
- MeRes100 - Product Status
- MeRes100 - Product Description
- MeRes100 - A Multi Center Randomized Control Study of MeRes100 Sirolimus Eluting BioResorbable Vascular Scaffold System in Treatment of Coronary Artery Disease Patients: MeRes - China
- MeRes100 - A Prospective, Multinational, Multicenter, Single Arm, Open Label, Pilot Clinical Study of MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System in the Treatment of De-novo Native Coronary Artery Lesions: MeRes-1 Extend
- MeRes100 - To Compare the Safety and Performance of MeRes100 Sirolimus Eluting BioResorbable Vascular Scaffold System Versus Contemporary DES Platforms in Patients With de Novo Coronary Artery Lesions
- Miltonia-UNO - Product Status
- Miltonia-UNO - Product Description
- Mitva - Product Status
- Mitva - Product Description
- MyVal 2 - Product Status
- MyVal 2 - Product Description
- MyVal Genesis - Product Status
- MyVal Genesis - Product Description
- MyVal Hexa - Product Status
- MyVal Hexa - Product Description
- Myval Rondevu - Product Status
- Myval Rondevu - Product Description
- MyVal S/Ex - Product Status
- MyVal S/Ex - Product Description
- Navigator 2 - Product Status
- Navigator 2 - Product Description
- Navigator Neo - Product Status
- Navigator Neo - Product Description
- Navigator Rondevu - Product Status
- Navigator Rondevu - Product Description
- OctAlign - Product Status
- OctAlign - Product Description
- PeriTi - Product Status
- PeriTi - Product Description
- Plugit - Product Status
- Plugit - Product Description
- Python Novela - Product Status
- Python Novela - Product Description
- Senarius - Product Status
- Senarius - Product Description
- Zotomime - Product Status
- Zotomime - Product Description
- Meril Life Sciences Pvt Ltd, Key Employees
- Meril Life Sciences Pvt Ltd, Subsidiaries
- Glossary
- Meril Life Sciences Pvt Ltd Pipeline Products by Equipment Type
- Meril Life Sciences Pvt Ltd Pipeline Products by Development Stage
- Meril Life Sciences Pvt Ltd Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Biorad Medisys Pvt Ltd
- JK Medical Systems Pvt Ltd
- Sterimed Medical Devices Pvt Ltd
- Teleflex Medical Pvt Ltd
- Trivitron Healthcare Pvt Ltd
- JK Medical Systems Pvt Ltd
- Sterimed Medical Devices Pvt Ltd
- Biorad Medisys Pvt Ltd
- Trivitron Healthcare Pvt Ltd
- Teleflex Medical Pvt Ltd
